US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist

26.900
-0.510-1.86%

Close Feb 25 16:00 ET

26.900
0.0000.00%

Post 20:01 ET

3.35BMarket Cap-13.25P/E (TTM)

Apellis Pharmaceuticals Stock Forum

Sign in to post a comment

Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN

$Apellis Pharmaceuticals (APLS.US)$
Breakthrough for Rare Kidney Diseases: EMA Reviews First Potential Treatment Following 68% Disease Reduction

Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN

Nov 27, 2024 09:07

$Apellis Pharmaceuticals (APLS.US)$
finally moving

Oct 26, 2024 13:11

$Apellis Pharmaceuticals (APLS.US)$

Oct 25, 2024 11:01

$Emergent BioSolutions (EBS.US)$ bounce back you &*#@!
$Moderna (MRNA.US)$ $Apellis Pharmaceuticals (APLS.US)$ $Clover Health (CLOV.US)$

1

3

Oct 14, 2024 17:17

$Apellis Pharmaceuticals (APLS.US)$ should be 40 😁

2

Oct 14, 2024 13:35

$Apellis Pharmaceuticals (APLS.US)$

Oct 14, 2024 09:18

$Apellis Pharmaceuticals (APLS.US)$ 40 😁

Sep 24, 2024 17:10

$Apellis Pharmaceuticals (APLS.US)$👈 wallstreet seems to like this stock still giving them a nice price target
$Emergent BioSolutions (EBS.US)$
$Novocure (NVCR.US)$

2

3

Sep 20, 2024 04:33

$Apellis Pharmaceuticals (APLS.US)$

Sep 5, 2024 14:47

$Apellis Pharmaceuticals (APLS.US)$Apellis Pharmaceuticals, Inc. (APLS): Among the Best Mid-Cap Healthcare Stocks To Buy Now

1

1

No comment yet